Da PNH er sjælden, blev Soliris udpeget som "lægemiddel til sjældne sygdomme" den 17. oktober 2003.
Because the number of patients with PNH is low, the disease is considered ‘ rare’, and Soliris was designated an ‘ orphan medicine ’ (a medicine used in rare diseases) on 17 October 2003.